Nuclear Medicine and Biology
Volume 35, Issue 7 , Pages 733-740 , October 2008

Sensitive determination of specific radioactivity of positron emission tomography radiopharmaceuticals by radio high-performance liquid chromatography with fluorescence detection

  • Ryuji Nakao

      Affiliations

    • Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 43 206 4041; fax: +81 43 206 3261.
    • ,
  • Kenji Furutsuka

      Affiliations

    • Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • Sumitomo Accelerator Service, Tokyo 141-8686, Japan
    • ,
  • Masatoshi Yamaguchi

      Affiliations

    • Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan
    • ,
  • Kazutoshi Suzuki

      Affiliations

    • Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan

Received 23 May 2008 ,Revised 12 June 2008 ,Accepted 19 June 2008.

References 

  1. Chen JJ, Huang SJ, Finn RD, Kirk KL, Francis BE, Adams HR, et al. Quality control procedure for 6-[18F]fluoro-l-DOPA: a presynaptic PET imaging ligand for brain dopamine neurons. J Nucl Med. 1989;30:1249–1256
  2. Alexoff DL, Casati R, Fowler JS, Wolf AP, Shea C, Schlyer DJ, et al. Ion chromatographic analysis of high specific activity [18F]FDG preparations and detection of the chemical impurity 2-deoxy-2-chrolo-d-glucose. Appl Radiat Isot. 1992;43:1313–1322
  3. Nakao R, Furutuka K, Yamaguchi M, Suzuki K. Quality control of PET radiopharmaceuticals using HPLC with electrochemical detection. Nucl Med Biol. 2006;33:441–447
  4. Hyllbrant B, Tyrefors N, Markides KE, Langstrom B. On the use of liquid chromatography with radio- and ultraviolet absorbance detection coupled to mass spectrometry for improved sensitivity and selectivity in determination of specific radioactivity of radiopharmaceuticals. J Pharm Biomed Anal. 1999;20:493–501
  5. Macasek F, Bruder P, Patakyova A, Buriova E. Atmospheric pressure electrospray ionization mass spectra of glucose and 2-fluorodeoxyglucose for quantitative analysis of 2-fluorodeoxyglucose by high-performance liquid chromatography. Eur J Mass Spectrom. 2003;9:129–137
  6. Noguchi J, Suzuki K. Automated synthesis of the ultra high specific activity of [11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl Med Biol. 2003;30:335–343
  7. Suhara T, Sudo Y, Okauchi T, Maeda J, Kawabe K, Suzuki K, et al. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. Int J Neuropsychopharmacol. 1999;2:73–82
  8. Ohkura Y, Kai M, Nohta H. Fluorogenic reactions for biomedical chromatography. J Chromatogr B. 1994;659:85–107
  9. Martin MA, Lin B, Del CB. The use of fluorescent probes in pharmaceutical analysis. J Pharm Biomed Anal. 1988;6:573–583
  10. Nakao R, Ito T, Yamaguchi M, Suzuki K. Improved quality control of [18F]FDG by HPLC with UV detection. Nucl Med Biol. 2005;32:907–912
  11. Honda S, Matsuda Y, Takahashi M, Kakehi K. Fluorimetric determination of reducing carbohydrates with 2-cyanoasetamide and application to automated analysis of carbohydrates as borate complex. Anal Chem. 1980;52:1079–1082
  12. Honda S, Kakehi K, Fujikawa K, Oka Y, Takahashi M. Mechanism of the reaction of reducing carbohydrates with 2-cyanoacetamide, used for postcolumn labeling in high performance liquid chromatography for photometric, fluorimetric and electrochemical detection. Carbohydr Res. 1988;183:59–69
  13. Chaidedgumjorn A, Suzuki A, Toyoda H, Toida T, Imanari T, Linhardt RJ. Conductivity detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans separated by high-performance size-exclusion chromatography. J Chromatogr A. 2002;959:95–102
  14. Volpi N. Separation of capsular polysaccharide-K4- and defructosylated-K4-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection. Anal Biochem. 2004;330:359–361
  15. Irie T, Fukushi K, Akimoto Y, Tamagami H, Nozaki T. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. Nucl Med Biol. 1994;21:801–808
  16. Kikuchi T, Fukushi K, Ikota N, Ueda T, Nagatsuka S, Arano Y, et al. Synthesis of piperidinyl and pyrrolidinyl butyrates for potential in vivo measurement of cerebral butyrylcholinesterase activity. J Labelled Cpd Radiopharm. 2001;44:31–41
  17. Biel JH, Abood LG, Hoya WK, Leiser HA, Nuhfer PA, Klucheskyc EF. Central stimulants: II. Cholinergic blocking agents. J Org Chem. 1961;26:4096–4103
  18. Mosdzianowski C, Lemaire C, Lauricella B, Aerts J, Morelle JL, Gobert F, et al. Routine and multi-curie level productions of [18F]FDG using an alkaline hydrolysis on solid support. J Labelled Cpd Radiopharm. 1999;42:515–516
  19. Nohta H, Sakai F, Kai M, Ohkura Y, Hara S, Yamaguchi M. 2-Aminothiophenols as fluorogenic reagents for aromatic aldehydes. Anal Chim Acta. 1993;282:625–631
  20. Turton DR, Yau K. HPLC UV detector response to radioactivity in the analysis of PET radiotracer. J Labelled Cpd Radiopharm. 2005;48:S139

PII: S0969-8051(08)00144-3

doi: 10.1016/j.nucmedbio.2008.06.005

Nuclear Medicine and Biology
Volume 35, Issue 7 , Pages 733-740 , October 2008

Article Tools

* Image Usage & Resolution